Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
Publication
, Journal Article
Blazer, DG
Published in: Am J Geriatr Psychiatry
2004
Duke Scholars
Published In
Am J Geriatr Psychiatry
DOI
ISSN
1064-7481
Publication Date
2004
Volume
12
Issue
6
Start / End Page
658 / 659
Location
England
Related Subject Headings
- Survival Rate
- Risperidone
- Risk
- Olanzapine
- Middle Aged
- Male
- Humans
- Haloperidol
- Geriatrics
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Blazer, D. G. (2004). Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol. Am J Geriatr Psychiatry, 12(6), 658–659. https://doi.org/10.1176/appi.ajgp.12.6.658-A
Blazer, Dan G. “Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.” Am J Geriatr Psychiatry 12, no. 6 (2004): 658–59. https://doi.org/10.1176/appi.ajgp.12.6.658-A.
Blazer DG. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol. Am J Geriatr Psychiatry. 2004;12(6):658–9.
Blazer, Dan G. “Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.” Am J Geriatr Psychiatry, vol. 12, no. 6, 2004, pp. 658–59. Pubmed, doi:10.1176/appi.ajgp.12.6.658-A.
Blazer DG. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol. Am J Geriatr Psychiatry. 2004;12(6):658–659.
Published In
Am J Geriatr Psychiatry
DOI
ISSN
1064-7481
Publication Date
2004
Volume
12
Issue
6
Start / End Page
658 / 659
Location
England
Related Subject Headings
- Survival Rate
- Risperidone
- Risk
- Olanzapine
- Middle Aged
- Male
- Humans
- Haloperidol
- Geriatrics
- Female